查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1854567

細胞庫外包市場按服務類型、細胞類型、應用和最終用戶分類 - 全球預測 2025-2032

Cell Banking Outsourcing Market by Service Type, Cell Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，細胞庫外包市場規模將成長 480.6 億美元，複合年成長率為 16.08%。

主要市場統計數據
基準年 2024 145.7億美元
預計年份：2025年 169.6億美元
預測年份：2032年 480.6億美元
複合年成長率 (%) 16.08%

細胞庫外包涉及科學嚴謹性、商業性需求和營運複雜性三者之間的交匯點。各機構依賴外部合作夥伴來保存關鍵生物資產，確保研發和生產流程的連續性，並降低因內部產能限制而產生的風險。隨著治療方式的不斷湧現和研發週期的縮短，外包細胞庫的角色正變得日益策略化，而不再只是交易性的。這種轉變要求決策者重新評估其合作夥伴選擇標準、管治模式和品質監管措施，以滿足對可追溯性、可重複性和供應彈性的更高期望。

同時，冷凍保存、細胞擴增平台和分析檢測等技術的成熟度不斷提升，外部供應商能夠可靠交付的服務範圍也隨之擴大。因此，相關人員必須權衡技術能力、供應鏈完整性、監管合規性和成本動態。本出版物透過揭示細胞庫外包為何如今備受董事會關注，為深入分析奠定了基礎。它闡明了促使企業選擇外包的關鍵促進因素、必須評估的營運特性以及必須規避的風險。基於科學和商業性現實的討論，使讀者能夠從穩健性、可擴展性和戰略靈活性為優先考慮的視角來解讀以下章節。

透過技術創新、供應鏈改革和相關人員之間的監管趨同，一場變革性的轉變正在重新定義細胞庫外包。

市場參與企業正經歷一場變革性的轉變，這場轉變正在再形成細胞庫外包的採購、管理和治理。自動化技術的進步和封閉式細胞庫的擴展正在減少人工操作帶來的差異，並提高人們對服務水準一致性和可追溯性的期望。這些技術變革伴隨著供應鏈模式的重新調整。供應商正在投資於整合低溫運輸解決方案、冗餘儲存容量和地理分散式金庫，以降低運輸風險並確保業務連續性。因此，這些投資正在改變定價結構以及買賣雙方之間的合約承諾的性質。

主要司法管轄區的監管趨同也影響供應商的能力。文件記錄、微生物監測和基因鑑定方面要求的統一推動了工作流程的標準化，而針對細胞和基因療法的新指南則鼓勵對物料輸送進行更嚴格的監控。同時，策略整合和專業細分領域供應商的湧現等商業性動態正在建構一個規模化和專業化並存的多層次生態系統。因此，企業在評估外包合作夥伴時，不僅需要檢視其當前的技術能力，還需要檢視其適應快速變化的監管和技術變革的能力，從而確保未來的供應關係。

對2025年美國關稅對細胞庫外包營運、採購和商業策略的累積影響全面評估

2025年美國關稅政策引入了一系列新的動態，對細胞庫外包生態系統產生了連鎖反應。從一次性反應器袋和管瓶到分析設備和試劑，各種專用組件的採購成本都因進口商品加徵關稅而面臨上升壓力。為此，許多公司重新評估了供應商資格認證策略，優先考慮擁有本土生產或關稅減免計畫的供應商。這種權衡取捨影響了前置作業時間、合約談判以及維持細胞庫穩定運作所需的上游投入的整體可靠性。

除了直接的成本影響外，關稅還促使採購區域和庫存管理策略轉變。一些客戶增加了緩衝庫存或轉向多資訊來源供應策略，以保護其營運免受運輸波動和關稅不確定性。另一些客戶則加快了對區域供應商的投資，這些供應商能夠提供關鍵服務本地化，並減輕跨境關稅波動的影響。這些行為變化影響了與物流供應商的合約彈性、倉儲能力規劃以及成本轉嫁。更重要的是，監管合規和文件要求進一步加劇了這些營運調整的複雜性，因為貨物在不同司法管轄區之間運輸通常需要補充認證，這會增加供應商工作流程中的時間和行政負擔。

關鍵的細分洞察，揭示了跨服務類型、單元類型、應用程式和最終用戶的機會路徑，從而確定外包投資和夥伴關係的優先順序。

有效的細分主導方法能夠揭示外包策略的重點所在，以及為何某些服務組合能創造不成比例的價值。分析服務類型可知，細胞擴增服務、物流服務、品管測試和倉儲服務構成了外包產品組合的核心。在細胞擴增服務中，客製化細胞擴增和標準細胞擴增的區別決定了合作夥伴是需要提供客製化的製程開發，還是需要遵循固定的通訊協定；物流涵蓋了從低溫運輸物流到庫存管理的廣泛職責；測試需求則分為基因表徵、安全性測試和活力測試。這些服務水準上的細微差別會影響合約風險分配以及買方所需的技術監督程度。

透過對細胞類型的分析，可以進一步闡明：哺乳動物細胞、微生物細胞和幹細胞各自具有獨特的處理、冷凍保存和分析要求。哺乳動物細胞工作流程又細分為CHO細胞、融合瘤和NS0細胞；微生物細胞工作流程主要集中於大腸桿菌和酵母菌細胞；幹細胞產品涵蓋造血幹細胞、誘導性多功能幹細胞幹細胞和間質幹細胞。生物製藥生產可分為單株抗體生產和蛋白質治療，基因治療可分為基於腺相關病毒（AAV）的療法和慢病毒療法，再生醫學可分為細胞療法和組織工程，疫苗生產可分為重組疫苗和病毒疫苗。最後，終端用戶細分揭示了學術機構、生物技術公司、委外研發機構（ CRO）和製藥公司在風險接受度和採購週期方面的差異。在生技公司內部，大型生技公司和小型生技公司的需求也有差異；在CRO內部，臨床CRO和臨床前CRO也有差異。整合這些細分視角，決策者可以根據每個細分市場的技術、監管和商業性概況，優先考慮供應商選擇、合約設計和產能投資。

區域戰略觀點，重點關注美洲、歐洲、中東和非洲以及亞太地區的不同需求促進因素、基礎設施考量和監管差異。

區域動態對企業建構和管理細胞庫外包關係的方式有顯著影響。美洲市場的特點是：對整合服務模式的需求集中，先進的治療藥物研發蓬勃發展，以及強大的物流網路支援快速商業化。該地區的供應商通常強調可擴展性、監管合規性和端到端可追溯性作為其差異化優勢。相較之下，歐洲、中東和非洲的法律規範和基礎設施成熟度各不相同，迫使供應商提供適應性強的合規支援、跨境物流知識以及針對不同地區的文檔編制方法，以滿足各國不同的要求。

亞太地區的特點是產能快速擴張和管理體制不斷演變，這促使企業加大對低溫運輸基礎設施和本地化生產的投資，以應對該地區對生物製藥和疫苗生產日益成長的需求。一些全球供應商在地理位置分散地設立工廠，以規避地緣政治和關稅風險；而另一些區域性專業供應商則利用接近性優勢和成本結構，服務於快速成長的區域市場。因此，對於考慮外包決策的企業而言，制定基於地理位置的策略至關重要，因為位置會影響前置作業時間、與監管機構的互動、緊急應變計畫以及細胞庫營運的整體韌性。

深入分析塑造細胞庫外包生態系統的競爭對手和合作夥伴，並專注於差異化能力、技術領先地位和策略聯盟。

本公司在細胞庫外包領域的定位體現了其技術能力、品質系統成熟度和商業性靈活性的綜合考量。成熟的研發公司往往以規模優勢、廣泛的服務組合和深厚的監管經驗脫穎而出，吸引著那些推動全球研發專案的大型製藥企業。為了最大限度地降低關鍵任務風險，這些公司會投資於冗餘儲存、檢驗的低溫運輸合作夥伴以及完善的品管系統。同時，規模較小、更專業化的供應商正透過專注於滿足特定客戶需求並加速早期研發的利基服務（例如複雜的基因表徵檢測或客製化細胞擴增方案）而獲得市場認可。

策略聯盟和併購也在推動競爭，一些公司透過合作提供整合儲存、物流和分析測試的整合解決方案。雖然這種合作模式可以減少供應商數量，簡化買方的管治，但也需要仔細審查合約條款和資料交換通訊協定。因此，對於客戶而言，選擇供應商不僅要考慮近期的技術契合度，還要考慮長期藍圖的一致性、在自動化和分析方面的投資，以及在保持合規性的同時實現規模化的能力。這種細緻的評估有助於識別那些能力與企業風險接受度和創新策略相符的供應商。

為產業領導者提供可操作的建議，以最佳化外包策略、降低供應鏈風險並加速能力發展

產業領導者可以採取實際措施，降低細胞庫外包固有的系統性風險，並從中獲取價值。首先，他們應優先考慮對供應商進行多方面的資格認證，以評估其技術能力、供應鏈韌性和監管記錄。合約結構應具備靈活性，例如費用轉嫁、服務水準調整以及可擴展的產能，以適應研發階段的過渡。投資於包含採購、品質、監管和研發等相關人員的跨職能管治結構，可以提高決策質量，並在出現偏差時加快問題解決速度。

其次，企業應將標準化服務外包給能夠提供可預測的成本和品質的合作夥伴，同時對差異化能力進行策略性聯合投資，例如專業的可行性測試和客製化的細胞擴增方法。此外，制定區域採購策略，充分利用美洲、歐洲、中東和非洲以及亞太地區的供應商，可以降低地緣政治和關稅風險。最後，領導者應秉持持續改進的理念，與供應商簽訂資料共用協議並利用績效儀錶板來監控趨勢、識別預警訊號並推動流程改善。綜合運用這些措施，可以發展出兼顧創新速度和營運可靠性的切實可行的藍圖。

一套嚴謹的調查方法，詳細闡述了資料收集、相關人員參與、檢驗技術以及用於得出洞見的分析框架。

該分析基於混合方法研究框架，整合了相關人員的定性訪談、一級供應商評估和跨職能文件審查。第一階段包括與採購、品質和研發部門的高階主管進行結構化對話，以發現技術交接、監管要求和物流韌性方面的痛點。同時，透過標準化問捲和第三方對設施認證及品管系統的檢驗，進行了供應商能力評估。這些資訊被整合起來，用於識別外包安排中通用的服務差異化模式和失效模式。

為確保研究結果的可靠性，我們採用三角驗證法，對現有的監管指南和公開的設施認證及夥伴關係資訊進行核實。我們的分析框架著重於風險敞口、能力匹配和策略靈活性，以評估機構應將資源集中在哪些方面。在整個過程中，我們關注資料來源和潛在偏差，並透過後續檢驗和情境分析來協調相互矛盾的資訊。此調查方法結合了實務經驗、結構化的服務提供者評估和跨區域情境分析，從而得出切實可行的結論。

結論：綜合策略洞察、新興風險與機遇，以及細胞庫外包中對適應性夥伴模式的需求

本執行摘要的綜合結論表明，細胞庫外包不再只是採購，而是一項支持更廣泛的生物製藥價值鏈的策略能力。能夠將卓越的細胞處理技術與穩健的物流、合規的監管和透明的數據管治相結合的研發企業，將更有能力滿足研發企業和生產商不斷變化的需求。從關稅主導的採購模式轉變到日益嚴格的監管審查，新的物流意味著企業必須在設計外包關係時兼顧靈活性、冗餘性和清晰的績效指標。

最後，企業必須將外包視為自身內部能力的延伸，而非孤立的成本中心。透過應用本報告中的市場區隔洞察、區域背景和實用建議，決策者可以更好地將合作夥伴選擇和管治模式與自身策略重點相契合。這種合作有助於提高研發和生產的連續性，減少營運風險，並加速先進療法惠及病患的進程。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 採用一次性反應器系統來簡化細胞庫工作流程並降低交叉污染的風險
  • 整合先進的數位雙胞胎和人工智慧建模技術，預測細胞庫性能並最佳化流程
  • 擴展模組化低溫運輸物流網路，以支援冷凍保存細胞庫的全球分銷
  • 在單元格儲存設施中實施連續監測感測器和物聯網平台，以實現即時品管
  • 提供綜合細胞庫和基因編輯服務的合約開發和生產組織的出現
  • 監管趨同，朝著統一的全球標準邁進，這推動了對細胞庫表徵和可比性的要求。
  • 對客製化主細胞庫的需求日益成長，以滿足個人化細胞治療計畫的需求。

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依服務類型分類的細胞庫外包市場

  • 細胞增殖
    • 客製化細胞生長
    • 標準細胞生長
  • 物流服務
    • 低溫運輸物流
    • 庫存管理
  • 品管測試
    • 遺傳特徵
    • 安全檢查
    • 可行性測試
  • 儲存服務

9. 依細胞類型分類的細胞庫外包市場

  • 哺乳動物細胞
    • CHO細胞
    • 融合瘤
    • NS0細胞
  • 微生物細胞
    • 大腸桿菌細胞
    • 酵母菌細胞
  • 幹細胞
    • 造血幹細胞
    • 誘導性多功能細胞
    • 間質幹細胞

第10章 依應用分類的細胞庫外包市場

  • 生物製藥生產
    • 單株抗體生產
    • 蛋白質療法
  • 基因治療
    • 基於AAV的治療方法
    • 慢病毒療法
  • 再生醫學
    • 細胞療法
    • 組織工程
  • 疫苗生產
    • 重組疫苗
    • 病毒疫苗

第11章 以最終用戶分類的細胞庫外包市場

  • 學術機構
  • 生技公司
    • 主要生物技術公司
    • 小型生技公司
  • 合約研究組織
    • 臨床合約研究組織
    • 臨床前合約研究組織
  • 製藥公司

12. 各區域的細胞庫外包市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 依群體分類的細胞庫外包市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國細胞庫外包市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Lonza Group AG
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Cytiva Uppsala AB
    • Fujifilm Diosynth BIoTechnologies UK Limited
    • WuXi AppTec Co., Ltd.
    • AGC Biologics Inc.
    • Catalent, Inc.
    • Cobra Biologics Group Limited
    • Selexis SA
Product Code: MRR-F927BA462CB7

The Cell Banking Outsourcing Market is projected to grow by USD 48.06 billion at a CAGR of 16.08% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 14.57 billion
Estimated Year [2025] USD 16.96 billion
Forecast Year [2032] USD 48.06 billion
CAGR (%) 16.08%

The landscape of cell banking outsourcing sits at the intersection of scientific rigor, commercial urgency, and operational complexity. Organizations rely on external partners to preserve critical biological assets, ensure continuity of research and manufacturing pipelines, and mitigate risks that arise from constrained internal capacity. As therapeutic modalities proliferate and development timelines compress, the role of outsourced cell banking becomes increasingly strategic rather than purely transactional. This evolution demands that decision-makers reassess partner selection criteria, governance models, and quality oversight practices to align with higher expectations around traceability, reproducibility, and supply resilience.

In parallel, technological maturation in cryopreservation, cell expansion platforms, and analytical testing has expanded what external providers can reliably deliver. Consequently, stakeholders must balance technical capability with supply chain integrity, regulatory alignment, and cost-to-serve dynamics. This introduction sets the context for deeper analysis by framing why cell banking outsourcing now commands board-level attention. It clarifies the primary drivers that compel organizations to outsource, the operational attributes they must evaluate, and the risks they must mitigate. By grounding the discussion in both scientific and commercial realities, readers are positioned to interpret subsequent sections through a lens that prioritizes robustness, scalability, and strategic flexibility.

Transformative shifts redefining cell banking outsourcing through technology innovation, supply chain reinvention, and regulatory convergence across stakeholders

Market participants are experiencing transformative shifts that are reshaping how cell banking outsourcing is sourced, managed, and governed. Advances in automation and closed-system cell expansion are reducing manual variability, thereby elevating expectations for service-level consistency and traceability. These technological changes are accompanied by a reorientation of supply chain models: providers are investing in integrated cold chain solutions, redundant storage capacity, and geographically distributed vaults to reduce transit risk and ensure continuity. In turn, these investments are altering price structures and the nature of contractual commitments between buyers and providers.

Regulatory convergence across major jurisdictions is also influencing provider capabilities. Harmonized expectations for documentation, microbial surveillance, and genetic characterization are driving standardization across operating procedures, while new guidance on cell and gene therapies prompts more rigorous oversight of source material handling. Concurrently, commercial dynamics such as strategic consolidation and the emergence of specialized niche providers are creating a layered ecosystem where scale and specialization coexist. As a result, organizations must evaluate outsourcing partners not only on current technical competency but also on the ability to adapt to rapid regulatory and technological change, thereby securing future-proofed supply relationships.

Comprehensive assessment of the cumulative implications of United States tariff actions in 2025 on cell banking outsourcing operations, sourcing, and commercial strategies

United States tariff actions enacted in 2025 introduced a new set of dynamics that ripple through the cell banking outsourcing ecosystem. Procurement of specialized components-ranging from single-use bioreactor bags and cryovials to analytical instruments and reagents-faces elevated cost pressures when tariffs apply to imported goods. In response, many organizations re-evaluated vendor qualification strategies and prioritized suppliers with onshore manufacturing or tariff-mitigation plans. This rebalancing has affected lead times, contract negotiations, and the overall reliability of upstream inputs required for consistent cell banking operations.

Beyond direct cost implications, tariffs have driven strategic shifts in sourcing geography and inventory policy. Some clients increased buffer stocks or shifted to multi-sourced supply strategies to insulate operations from transit volatility and tariff uncertainty. Others accelerated investment in regional providers that could localize critical services and reduce exposure to cross-border tariff variability. These behavioral changes have implications for logistics providers, storage capacity planning, and contractual flexibility around pass-through costs. Importantly, regulatory compliance and documentation requirements have compounded these operational adjustments, because goods moving across different jurisdictions frequently necessitate supplementary certification, which can introduce additional time and administrative overhead into provider workflows.

Key segmentation insights revealing opportunity pathways across service types, cell types, applications, and end users to prioritize outsourcing investments and partnerships

An effective segmentation-led approach reveals where outsourcing strategies should be concentrated and why certain service combinations create disproportionate value. Examining Service Type shows how Cell Expansion Services, Logistics Services, Quality Control Testing, and Storage Services form the core portfolio of outsourced offerings; within cell expansion, the distinction between Custom Cell Expansion and Standard Cell Expansion determines whether a partner must provide bespoke process development or follow fixed protocols, while logistics responsibilities range from Cold Chain Logistics to Inventory Management, and testing expectations divide across Genetic Characterization, Safety Testing, and Viability Testing. These service-level nuances shape contractual risk allocation and the level of technical oversight required from buyers.

Exploring Cell Type provides further clarity: Mammalian Cells, Microbial Cells, and Stem Cells each carry unique handling, cryopreservation, and analytical demands; mammalian workstreams subdivide into CHO Cells, Hybridoma Cells, and NS0 Cells, while microbial workflows focus on E Coli Cells and Yeast Cells, and stem cell offerings span Hematopoietic Stem Cells, Induced Pluripotent Stem Cells, and Mesenchymal Stem Cells. Application-based segmentation highlights where demand intensity and regulatory scrutiny intersect; Biopharmaceutical Manufacturing encompasses MAb Production and Protein Therapeutics, Gene Therapy covers AAV-Based Therapies and Lentiviral Therapies, Regenerative Medicine includes Cell Therapy and Tissue Engineering, and Vaccine Production differentiates between Recombinant Vaccines and Viral Vaccines. Finally, End User segmentation shows how Academic Institutes, Biotechnology Companies, Contract Research Organizations, and Pharmaceutical Companies present divergent risk appetites and procurement cycles; within biotech, needs further diverge between Large Biotech and Small Biotech, and CROs distinguish Clinical CROs from Preclinical CROs. Integrating these segmentation lenses allows decision-makers to prioritize provider selection, contract design, and capability investments according to the technical, regulatory, and commercial contours of each niche.

Regional strategic perspectives highlighting differing demand drivers, infrastructure considerations, and regulatory nuances across the Americas, EMEA, and Asia-Pacific

Regional dynamics materially influence how organizations construct and manage cell banking outsourcing relationships. In the Americas, the market is characterized by a concentrated demand for integrated service models, a high prevalence of advanced therapeutics development, and robust logistics networks that support rapid commercialization pathways. Providers in this region often emphasize scalability, regulatory readiness, and end-to-end traceability as differentiators. Conversely, Europe, Middle East & Africa features a mosaic of regulatory frameworks and infrastructure maturity, which compels providers to offer adaptable compliance support, cross-border logistics expertise, and region-specific documentation practices that meet diverse national requirements.

Asia-Pacific presents a distinct combination of rapid capacity expansion and evolving regulatory regimes; investment in cold chain infrastructure and localized production has grown in response to increasing regional demand for biopharmaceutical manufacturing and vaccine production. These regional differences shape supplier ecosystems: some global providers maintain geographically distributed facilities to hedge geopolitical and tariff risks, while regional specialists capitalize on proximity advantages and cost structures to serve fast-growing local markets. Consequently, a geographically informed strategy is essential for organizations contemplating outsourcing decisions, since location influences lead times, regulatory interactions, contingency planning, and the overall resilience of cell banking operations.

Competitive and collaborative company insights focused on capability differentiation, technology leadership, and strategic alliances shaping the cell banking outsourcing ecosystem

Company positioning in the cell banking outsourcing space reflects a blend of technological capability, quality systems maturity, and commercial agility. Established providers tend to differentiate through scale, broad service portfolios, and extensive regulatory experience that appeals to large pharmaceutical clients pursuing global development programs. These companies invest in redundant storage vaults, validated cold chain partners, and robust quality management systems to minimize mission-critical risks. At the same time, smaller and specialized providers gain traction by focusing on niche technical competencies-such as high-throughput genetic characterization or bespoke cell expansion protocols-that address specific client needs and accelerate early-stage development.

Strategic alliances and M&A activity also underpin competitive dynamics, with some companies forming partnerships to offer integrated solutions that combine storage, logistics, and analytical testing. These collaborative models can shorten vendor bouquets and simplify governance for buyers, but they also require careful scrutiny of contractual interfaces and data exchange protocols. For clients, vendor selection should therefore weigh not only immediate technical fit but also long-term roadmap alignment, investment in automation and analytics, and demonstrated ability to scale while maintaining compliance. This nuanced assessment helps to identify providers whose capabilities align with an organization's risk tolerance and innovation agenda.

Actionable recommendations for industry leaders to optimize outsourcing strategies, de-risk supply chains, and accelerate capability development with pragmatic steps

Industry leaders can take concrete steps to capture value and reduce exposure to systemic risks inherent in outsourced cell banking. First, they should prioritize multi-dimensional vendor qualification that evaluates technical performance, supply chain resilience, and regulatory track record. Contractual constructs must incorporate flexibility for tariff pass-throughs, service-level adjustments, and scalable capacity to accommodate development-stage transitions. Investing in cross-functional governance structures that include procurement, quality, regulatory, and R&D stakeholders will improve decision quality and accelerate issue resolution when deviations occur.

Second, organizations should pursue strategic co-investment in capabilities where differentiation matters, such as specialized viability testing or bespoke cell expansion methods, while outsourcing standardized services to partners capable of delivering predictable cost and quality profiles. In parallel, developing regional sourcing strategies that leverage providers in the Americas, Europe, Middle East & Africa, and Asia-Pacific can mitigate geopolitical and tariff exposures. Finally, leaders should adopt a continuous improvement mindset, leveraging data-sharing agreements and performance dashboards with providers to monitor trends, detect early warning signals, and drive process improvements. These actions combine to create a pragmatic roadmap for balancing innovation speed with operational reliability.

Robust research methodology explanation detailing data collection, stakeholder engagement, validation techniques, and analytical frameworks used to derive insights

This analysis is grounded in a mixed-methods research framework that integrates qualitative stakeholder interviews, primary supplier assessments, and cross-functional document review. The primary phase involved structured conversations with senior leaders across procurement, quality, and R&D to surface pain points related to technical handoffs, regulatory expectations, and logistics resilience. Concurrently, provider capability mapping was conducted through standardized questionnaires and third-party validation of facility credentials and quality management systems. These inputs were synthesized to identify patterns in service differentiation and common failure modes across outsourcing arrangements.

To ensure the robustness of insights, triangulation techniques were used to corroborate interview findings with available regulatory guidance and public disclosures about facility certifications and partnerships. Analytical frameworks focused on risk exposure, capability fit, and strategic flexibility to evaluate where organizations should concentrate resources. Throughout the process, attention was paid to data provenance and the potential for bias, with contradictory inputs reconciled through follow-up validation and scenario analysis. This methodology supports actionable conclusions by combining practitioner experience with structured provider assessment and cross-regional contextualization.

Conclusion synthesizing strategic findings, emergent risks and opportunities, and the imperative for adaptive partnering models in cell banking outsourcing

The synthesis of this executive summary underscores that cell banking outsourcing is no longer a simple procurement exercise but a strategic capability that underwrites the broader biopharma value chain. Providers that can combine technical excellence in cell handling with resilient logistics, regulatory readiness, and transparent data governance will be best positioned to meet the evolving needs of developers and manufacturers. Emerging pressures-from tariff-driven sourcing shifts to heightened regulatory scrutiny-mean that organizations must design outsourcing relationships with flexibility, redundancy, and clear performance metrics.

In closing, the imperative for organizations is to treat outsourcing as an extension of internal capability rather than an isolated cost center. By applying the segmentation insights, regional context, and practical recommendations contained in this report, decision-makers can better align partner selection and governance models to their strategic priorities. This alignment will enable more reliable research and manufacturing continuity, reduce operational surprises, and support the expedited delivery of advanced therapies to patients.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of single-use bioreactor systems to streamline cell banking workflows and reduce cross-contamination risk
  • 5.2. Integration of advanced digital twin and AI modeling for predictive cell bank performance and process optimization
  • 5.3. Expansion of modular cold chain logistics networks to support global distribution of cryopreserved cell banks
  • 5.4. Implementation of continuous monitoring sensors and IoT platforms for real-time quality control in cell storage facilities
  • 5.5. Emergence of contract development manufacturing organizations offering integrated cell banking and gene editing services
  • 5.6. Regulatory convergence on harmonized global standards driving cell bank characterization and comparability requirements
  • 5.7. Growing demand for customized master cell banks tailored to personalized cell therapy programs

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cell Banking Outsourcing Market, by Service Type

  • 8.1. Cell Expansion Services
    • 8.1.1. Custom Cell Expansion
    • 8.1.2. Standard Cell Expansion
  • 8.2. Logistics Services
    • 8.2.1. Cold Chain Logistics
    • 8.2.2. Inventory Management
  • 8.3. Quality Control Testing
    • 8.3.1. Genetic Characterization
    • 8.3.2. Safety Testing
    • 8.3.3. Viability Testing
  • 8.4. Storage Services

9. Cell Banking Outsourcing Market, by Cell Type

  • 9.1. Mammalian Cells
    • 9.1.1. CHO Cells
    • 9.1.2. Hybridoma Cells
    • 9.1.3. NS0 Cells
  • 9.2. Microbial Cells
    • 9.2.1. E Coli Cells
    • 9.2.2. Yeast Cells
  • 9.3. Stem Cells
    • 9.3.1. Hematopoietic Stem Cells
    • 9.3.2. Induced Pluripotent Stem Cells
    • 9.3.3. Mesenchymal Stem Cells

10. Cell Banking Outsourcing Market, by Application

  • 10.1. Biopharmaceutical Manufacturing
    • 10.1.1. MAb Production
    • 10.1.2. Protein Therapeutics
  • 10.2. Gene Therapy
    • 10.2.1. AAV-Based Therapies
    • 10.2.2. Lentiviral Therapies
  • 10.3. Regenerative Medicine
    • 10.3.1. Cell Therapy
    • 10.3.2. Tissue Engineering
  • 10.4. Vaccine Production
    • 10.4.1. Recombinant Vaccines
    • 10.4.2. Viral Vaccines

11. Cell Banking Outsourcing Market, by End User

  • 11.1. Academic Institutes
  • 11.2. Biotechnology Companies
    • 11.2.1. Large Biotech
    • 11.2.2. Small Biotech
  • 11.3. Contract Research Organizations
    • 11.3.1. Clinical CROs
    • 11.3.2. Preclinical CROs
  • 11.4. Pharmaceutical Companies

12. Cell Banking Outsourcing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cell Banking Outsourcing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cell Banking Outsourcing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Lonza Group AG
    • 15.3.2. Thermo Fisher Scientific Inc.
    • 15.3.3. Merck KGaA
    • 15.3.4. Cytiva Uppsala AB
    • 15.3.5. Fujifilm Diosynth Biotechnologies UK Limited
    • 15.3.6. WuXi AppTec Co., Ltd.
    • 15.3.7. AGC Biologics Inc.
    • 15.3.8. Catalent, Inc.
    • 15.3.9. Cobra Biologics Group Limited
    • 15.3.10. Selexis SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CELL BANKING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CELL BANKING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CELL BANKING OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYP